Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Kaneshige

Orthopaedic Trauma Honolulu, HI Medical Doctor

NPI 1871798132 CMS profile 701788

550 S Beretania St Ste 503, Honolulu, HI 96813

Open in the dashboard

General payments

$14,214

35 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Kaneshige of Honolulu, HI is reported in the CMS Open Payments database as having received $14,214 across 35 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 60th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,814 4
2023 General $4,481 5
2022 General $1,810 6
2021 General $1,418 4
2020 General $16 1
2019 General $3,675 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Kaneshige
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Jason Kaneshige were reported at $2,814. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Jason Kaneshige Orthopaedic Trauma median Middle half National median
2019 $3,675 $1,475 $264–$6,401 $163
2020 $16 $596 $120–$4,020 $114
2021 $1,418 $919 $171–$4,697 $132
2022 $1,810 $1,547 $272–$7,240 $149
2023 $4,481 $1,330 $247–$5,875 $160
2024 $0 $1,288 $277–$6,797 $164
2025 $2,814 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Citieffe, Inc. $5,286 2 payments
  2. Zimmer Biomet Holdings, Inc. $3,184 9 payments
  3. Smith+Nephew, Inc. $2,925 6 payments
  4. ImpactOrtho, Inc. $1,200 1 payment
  5. Ortho Development Corporation $570 4 payments
  6. Stryker Corporation $366 4 payments
  7. Amgen Inc. $246 3 payments
  8. Engage Uni, LLC $196 1 payment
  9. Total Joint Orthopedics, Inc. $157 1 payment
  10. NextStep Arthropedix, LLC $38 1 payment
  11. Other $45 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $9,499 8 payments
  2. Food and Beverage $2,070 23 payments
  3. Consulting Fee $1,400 1 payment
  4. Education $1,246 3 payments
Products named General payments · program years 2019–2025
  1. REAL INTELLIGENCE $2,741 2 payments
  2. Persona $1,594 1 payment
  3. Oxford $1,466 7 payments
  4. BKS TriMax $383 2 payments
  5. EVENITY $246 3 payments
  6. Balanced Knee Revision System $241 1 payment
  7. Engage Partial Knee System $196 1 payment
  8. BKS Uni $195 2 payments
  9. AXSOS $157 1 payment
  10. JOURNEY II $142 1 payment
  11. Other $1,322 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

465

Median for Orthopedic Surgery: 203

Drug cost

$3,967

Median for Orthopedic Surgery: $1,433

Branded share of claims

3.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 125 $1,870
Methylprednisolone Generic 79 $783
Oxycodone Hcl Generic 109 $541
Promethazine Hcl Generic 68 $360
Meloxicam Generic 22 $178
Ibuprofen Generic 14 $100
Tramadol Hcl Generic 33 $71
Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim Brand 15 $64

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 89 billing codes

Paid by Medicare

$231,303

Of which drugs: $7,835

Medicare patients

544

Average age 75

Services billed

3,592

350 women, 194 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 73%
High blood pressure 72%
Chronic kidney disease 27%
Diabetes 26%
Osteoporosis 21%
Ischemic heart disease 20%
Atrial fibrillation 15%
Cancer 13%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 96 578 $418

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

35 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Hawaii

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record